- Home
- TKLF vs NCNA Comparison
TKLF vs NCNA Comparison
Compare TKLF & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKLF | NCNA |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | Japan | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 13.8M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TKLF | NCNA |
|---|---|---|
| Price | $3.04 | $3.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.3K | ★ 58.0K |
| Earning Date | 12-19-2025 | 11-13-2025 |
| Dividend Yield | ★ 7.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $302,537,158.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.92 | ★ N/A |
| Revenue Growth | ★ 37.82 | N/A |
| 52 Week Low | $2.10 | $2.78 |
| 52 Week High | $4.32 | $330.00 |
Technical Indicators
Market Signals| Indicator | TKLF | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 61.66 | 48.55 |
| Support Level | $2.74 | $3.16 |
| Resistance Level | $3.14 | $4.55 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 91.13 | 43.82 |
Price Performance
Historical ComparisonAbout TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.